Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 5.17B USD
- Enterprise value
- 4.13B USD
- Trailing P/E
- —
- Forward P/E
- -20.53
- Price / sales
- —
- Price / book
- 5.63
- EV / EBITDA
- —
- Beta
- 2.26
- Dividend yield
- —
- Profit margin
- 0.00%
- Return on equity
- -64.09%
- Debt / equity
- 3.97
- Earnings growth
- —
- Revenue growth
- —
- Free cash flow
- 7.61M USD
- Operating cash flow
- -167.95M USD
- Shares outstanding
- 134.37M
- Sector
- Healthcare
- Industry
- Biotechnology
Updated Sep 2, 2026, 4:11 AM